Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15:11–20. https://doi.org/10.1038/nrgastro.2017.109.

Article  PubMed  Google Scholar 

Younossi ZM, Golabi P, Paik JM, Henry A, Van Dongen C, Henry L. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology. 2023;77:1335–47. https://doi.org/10.1097/HEP.0000000000000004.

Article  PubMed  Google Scholar 

Estes C, Razavi H, Loomba R, Younossi Z, Sanyal AJ. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology. 2018;67:123–33. https://doi.org/10.1002/hep.29466.

Article  CAS  PubMed  Google Scholar 

Loomba R, Friedman SL, Shulman GI. Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell. 2021;184:2537–64. https://doi.org/10.1016/j.cell.2021.04.015.

Article  CAS  PubMed  Google Scholar 

Yang J, Fernández-Galilea M, Martínez-Fernández L, González-Muniesa P, Pérez-Chávez A, Martínez JA, et al. Oxidative stress and non-alcoholic fatty liver disease: effects of omega-3 fatty acid supplementation. Nutrients. 2019;11:872. https://doi.org/10.3390/nu11040872.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sutti S, Albano E. Adaptive immunity: an emerging player in the progression of NAFLD. Nat Rev Gastroenterol Hepatol. 2020;17:81–92. https://doi.org/10.1038/s41575-019-0210-2.

Article  CAS  PubMed  Google Scholar 

Meli R, Mattace Raso G, Calignano A. Role of innate immune response in non-alcoholic fatty liver disease: metabolic complications and therapeutic tools. Front Immunol. 2014;5:177. https://doi.org/10.3389/fimmu.2014.00177.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hu B, Yang XR, Xu Y, Sun YF, Sun C, Guo W, et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res. 2014;20:6212–22. https://doi.org/10.1158/1078-0432.CCR-14-0442.

Article  CAS  PubMed  Google Scholar 

Chen JH, Zhai ET, Yuan YJ, Wu KM, Xu JB, Peng JJ, et al. Systemic immune-inflammation index for predicting prognosis of colorectal cancer. World J Gastroenterol. 2017;23:6261–72. https://doi.org/10.3748/wjg.v23.i34.6261.

Article  PubMed  PubMed Central  Google Scholar 

Xie R, Xiao M, Li L, Ma N, Liu M, Huang X, et al. Association between SII and hepatic steatosis and liver fibrosis: A population-based study. Front Immunol. 2022;13: 925690. https://doi.org/10.3389/fimmu.2022.925690.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Um YJ, Chang Y, Jung HS, Cho IY, Shin JH, Shin H, et al. Sleep duration, sleep quality, and the development of nonalcoholic fatty liver disease: a cohort study. Clin Transl Gastroenterol. 2021;12:00417.

Article  Google Scholar 

Bernsmeier C, Weisskopf DM, Pflueger MO, Mosimann J, Campana B, Terracciano L, et al. Sleep disruption and daytime sleepiness correlating with disease severity and insulin resistance in non-alcoholic fatty liver disease: a comparison with healthy controls. PLoS ONE. 2015;10: e0143293. https://doi.org/10.1371/journal.pone.0143293.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Takahashi A, Anzai Y, Kuroda M, Kokubun M, Kondo Y, Ogata T, et al. Effects of sleep quality on non-alcoholic fatty liver disease: a cross-sectional survey. BMJ Open. 2020;10: e039947. https://doi.org/10.1136/bmjopen-2020-039947.

Article  PubMed  PubMed Central  Google Scholar 

Briançon-Marjollet A, Weiszenstein M, Henri M, Thomas A, Godin-Ribuot D, Polak J. The impact of sleep disorders on glucose metabolism: endocrine and molecular mechanisms. Diabetol Metab Syndr. 2015;7:25. https://doi.org/10.1186/s13098-015-0018-3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Grandner MA, Sands-Lincoln MR, Pak VM, Garland SN. Sleep duration, cardiovascular disease, and proinflammatory biomarkers. Nat Sci Sleep. 2013;5:93–107. https://doi.org/10.2147/NSS.S31063.

Article  PubMed  PubMed Central  Google Scholar 

Wei YT, Lee PY, Lin CY, Chen HJ, Lin CC, Wu JS, et al. Non-alcoholic fatty liver disease among patients with sleep disorders: a Nationwide study of Taiwan. BMC Gastroenterol. 2020;20:32. https://doi.org/10.1186/s12876-020-1178-7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Curtin LR, Mohadjer LK, Dohrmann SM, Kruszon-Moran D, Mirel LB, Carroll MD, et al. National Health and Nutrition Examination Survey: sample design, 2007–2010. Vital Health Stat 2. 2013;(160):1–23

Zipf G, Chiappa M, Porter KS, Ostchega Y, Lewis BG, Dostal J. National health and nutrition examination survey: plan and operations, 1999–2010. Vital Health Stat 1. 2013;(56):1–37

CDC. National Center for Health Statistics Ethics Review Board (ERB). Available at: https://www.cdc.gov/nchs/nhanes/irba98.html [Accessed on 20 January 2024]

Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67:328–57. https://doi.org/10.1002/hep.29367.

Article  PubMed  Google Scholar 

Song Y, Guo W, Li Z, Guo D, Li Z, Li Y. Systemic immune-inflammation index is associated with hepatic steatosis: evidence from NHANES 2015–2018. Front Immunol. 2022. https://doi.org/10.3389/fimmu.2022.1058779.

Article  PubMed  PubMed Central  Google Scholar 

Cai Y, Chen M, Zhai W, Wang C. Interaction between trouble sleeping and depression on hypertension in the NHANES 2005–2018. BMC Public Health. 2022;22:481. https://doi.org/10.1186/s12889-022-12942-2.

Article  PubMed  PubMed Central  Google Scholar 

Ruhl CE, Everhart JE. Fatty liver indices in the multiethnic United States national health and nutrition examination survey. Aliment Pharmacol Ther. 2015;41:65–76. https://doi.org/10.1111/apt.13012.

Article  CAS  PubMed  Google Scholar 

Li L, Huang Q, Yang L, Zhang R, Gao L, Han X, et al. The association between non-alcoholic fatty liver disease (NAFLD) and advanced fibrosis with serological vitamin B12 markers: results from the NHANES 1999–2004. Nutrients. 2022;14:1224. https://doi.org/10.3390/nu14061224.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pan J, Hu Y, Pang N, Yang L. Association between dietary niacin Intake and nonalcoholic fatty liver disease: NHANES 2003–2018. Nutrients. 2023;15:4128. https://doi.org/10.3390/nu15194128.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice guidelines. Hypertension. 2018;71(6):1269–324. https://doi.org/10.1161/hyp.0000000000000066.

Article  CAS  PubMed  Google Scholar 

Menke A, Casagrande S, Geiss L, Cowie CC. Prevalence of and trends in diabetes among adults in the United States, 1988–2012. JAMA. 2015;314:1021–9. https://doi.org/10.1001/jama.2015.10029.

Article  CAS  PubMed  Google Scholar 

Hu XY, Liang YC, Zhang HH, Li HL, Liu DL. Association between the systemic immune-inflammation index and thyroid function in US adults. Mediators Inflamm. 2023;2023:5831858. https://doi.org/10.1155/2023/5831858.

Article  PubMed  PubMed Central  Google Scholar 

Kammerlander AA, Mayrhofer T, Ferencik M, Pagidipati NJ, Karady J, Ginsburg GS, et al. Association of metabolic phenotypes with coronary artery disease and cardiovascular events in patients with stable chest pain. Diabetes Care. 2021;44:1038–45. https://doi.org/10.2337/dc20-1760.

Article  PubMed  PubMed Central  Google Scholar 

Centers for Disease Control and Prevention (CDC) National Center for Health Statistics (NCHS) National health and nutrition exam